{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:34:57Z","timestamp":1761863697101},"reference-count":32,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.3960\/jslrt.56.135","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T22:24:33Z","timestamp":1490135073000},"page":"135-144","source":"Crossref","is-referenced-by-count":10,"title":["The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.3960","volume":"56","author":[{"given":"Noriaki","family":"Kawano","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Kuriyama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[{"name":"Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Marutsuka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichirou","family":"Minato","sequence":"additional","affiliation":[{"name":"Department of Neurology, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenobu","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Trauma and Critical Care Center, Faculty of Medicine, University of Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hematology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Research Unit for Human Disease Models, RIKEN Research Center for Allergy and Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H: Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481-492, 1977","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Yoshida M, Seiki M, Yamaguchi K, Takatsuki K: Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81:2534-2537, 1984","DOI":"10.1073\/pnas.81.8.2534"},{"key":"3","unstructured":"3 Tajima K, Kuroishi T: Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn J Clin Oncol 15:423-430, 1985"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Shimoyama M: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79:428-437, 1991","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"5","unstructured":"5 Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, <i>et al<\/i>.: A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113:375-382, 2001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, <i>et al<\/i>.: VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25:5458-5464, 2007","DOI":"10.1200\/JCO.2007.11.9958"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, <i>et al<\/i>.: Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J Clin Oncol 27:453-459, 2009","DOI":"10.1200\/JCO.2008.18.2428"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ishitsuka K, Tamura K: Treatment of adult T-cell leukemia\/lymphoma: past, present, and future. Eur J Haematol 80:185-196, 2008","DOI":"10.1111\/j.1600-0609.2007.01016.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Uozumi K: Treatment of adult T-cell leukemia. J Clin Exp Hematop 50:9-25, 2010","DOI":"10.3960\/jslrt.50.9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Tsukasaki K, Tobinai K: Clinical trials and treatment of ATL. Leuk Res Treat 2012:101754, 2012","DOI":"10.1155\/2012\/101754"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, <i>et al<\/i>.: Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma. Leukemia 19:829-834, 2005","DOI":"10.1038\/sj.leu.2403682"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, <i>et al<\/i>.: Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma. Blood 105:4143-4145, 2005","DOI":"10.1182\/blood-2004-11-4193"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Tanosaki R, Uike N, Utsunomiya A, Saburi Y, Masuda M, <i>et al<\/i>.: Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia\/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant 14:702-708, 2008","DOI":"10.1016\/j.bbmt.2008.03.010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, <i>et al<\/i>.: Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 116:1369-1376, 2010","DOI":"10.1182\/blood-2009-10-247510"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, <i>et al<\/i>.: Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 120:1734-1741, 2012","DOI":"10.1182\/blood-2012-03-414490"},{"key":"16","unstructured":"16 Yamada Y, Atogami S, Hasegawa H, Kamihira S, Soda M, <i>et al<\/i>.: Nationwide survey of adult T-cell leukemia\/lymphoma (ATL) in Japan. Rinsho Ketsueki 52:1765-1771, 2011 (<i>in Japanese<\/i>)"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Kawano N, Yoshida S, Kuriyama T, Tahara Y, Yamashita K, <i>et al<\/i>.: Clinical features and treatment outcomes of 81 patients with aggressive type adult T-cell leukemia-lymphoma at a single institution over a 7-year period (2006\u20132012). Intern Med 54:1489-1498, 2015","DOI":"10.2169\/internalmedicine.54.1953"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, <i>et al<\/i>.: Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28:1591-1598, 2010","DOI":"10.1200\/JCO.2009.25.3575"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, <i>et al<\/i>.: Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30:837-842, 2012","DOI":"10.1200\/JCO.2011.37.3472"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, <i>et al<\/i>.: Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169:672-682, 2015","DOI":"10.1111\/bjh.13338"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Niwa R, Shoji-Hosaka E, Sakurada M, Shinkawa T, Uchida K, <i>et al<\/i>.: Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma. Cancer Res 64:2127-2133, 2004","DOI":"10.1158\/0008-5472.CAN-03-2068"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Sugiyama D, Nishikawa H, Maeda Y, Nishioka M, Tanemura A, <i>et al<\/i>.: Anti-CCR4 mAb selectively depletes effector-type FoxP3<sup>+<\/sup>CD4<sup>+<\/sup> regulatory T cells, evoking antitumor immune responses in humans. Proc Natl Acad Sci U S A 110:17945-17950, 2013","DOI":"10.1073\/pnas.1316796110"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Motohashi K, Suzuki T, Kishimoto K, Numata A, Nakajima Y, <i>et al<\/i>.: Successful treatment of a patient with adult T cell leukemia\/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation. Int J Hematol 98:258-260, 2013","DOI":"10.1007\/s12185-013-1387-8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Ohgiya D, Machida S, Ichiki A, Amaki J, Aoyama Y, <i>et al<\/i>.: Strong effect of mogamulizumab on splenic residual disease of adult T cell leukemia\/lymphoma. Ann Hematol 93:719-720, 2014","DOI":"10.1007\/s00277-013-1874-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Inoue Y, Fuji S, Tanosaki R, Fukuda T: Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality. Bone Marrow Transplant [Published online: December 21, 2015, DOI: 10.1038\/bmt.2015.315]","DOI":"10.1038\/bmt.2015.315"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Haji S, Kiyasu J, Choi I, Suehiro Y, Toyoda K, <i>et al<\/i>.: Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia\/lymphoma. Bone Marrow Transplant 51:432-434, 2016","DOI":"10.1038\/bmt.2015.254"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Nagafuji K, Miyamoto T, Eto T, Kamimura T, Taniguchi S, <i>et al<\/i>.: Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study). J Hematol Oncol 6:14, 2013","DOI":"10.1186\/1756-8722-6-14"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, <i>et al<\/i>.: A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113:375-382, 2001","DOI":"10.1046\/j.1365-2141.2001.02737.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S: Donor-type CD4<sup>+<\/sup>CD25<sup>+<\/sup> regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196:389-399, 2002","DOI":"10.1084\/jem.20020399"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Kawamata T, Ohno N, Sato K, Kobayashi M, Jo N, <i>et al<\/i>.: A case of post-transplant adult T-cell leukemia\/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy. Springerplus 3:581, 2014","DOI":"10.1186\/2193-1801-3-581"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, <i>et al<\/i>.: Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood 119:2141-2148, 2012","DOI":"10.1182\/blood-2011-07-368233"},{"key":"32","unstructured":"32 Kawano N, Kuriyama T, Sonoda KH, Yoshida S, Yamashita K, <i>et al<\/i>.: Clinical impact of humanized CCR4 antibody (mogamulizumab) treatment on 14 patients with aggressive adult T-cell leukemia-lymphoma at a single institution over a 3-year period (2012\u20132014). Intern Med [<i>in press<\/i>]"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/56\/3\/56_135\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T06:02:57Z","timestamp":1601791377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/56\/3\/56_135\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.56.135","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}